1.
Article
in English
| IMSEAR
| ID: sea-92529
ABSTRACT
Enoxacin, a new 6-fluoroquinolone known to be active in vitro against most common pulmonary pathogens, was evaluated in comparison with ceftazidime, a third generation cephalosporin proven to be effective in the treatment of gram negative pneumonias. Clinical and microbiologic responses to therapy were satisfactory and comparable in both antibiotic groups. Enoxacin could be an effective alternative choice in the treatment of lower respiratory tract infections caused by gram negative organisms.
Subject(s)
Adult , Ceftazidime/therapeutic use , Enoxacin/therapeutic use , Female , Gram-Negative Bacterial Infections/drug therapy , Hospitalization , Humans , Male , Middle Aged , Pneumonia/drug therapy , Prospective Studies , Sputum/microbiology
2.
Indian J Pathol Microbiol
;
1985 Jan; 28(1): 17-23
Article
in English
| IMSEAR
| ID: sea-72707
Subject(s)
Animals , Bacteria, Anaerobic/drug effects , Bacterial Infections/drug therapy , Bacteroides Infections/drug therapy , Disease Models, Animal , Endocarditis/etiology , Enterocolitis/drug therapy , Fusobacterium Infections/etiology , Liver Abscess/drug therapy , Metronidazole/therapeutic use , Penicillins/therapeutic use , Peritonitis/etiology , Urinary Tract Infections/etiology
3.
Indian J Pediatr
;
1982 Jan-Feb; 49(396): 85-94
Article
in English
| IMSEAR
| ID: sea-84346
Subject(s)
Anaerobiosis , Bacteria/isolation & purification , Bacterial Infections/diagnosis , Child , Humans
4.
Indian J Pediatr
;
1981 Nov-Dec; 48(395): 727-38
Article
in English
| IMSEAR
| ID: sea-82322